We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.
HOUSTON, TX, June 13, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA...
HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap...
HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided...
HOUSTON, TX, May 22, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) is pleased to announce its new division, Nexalin America, has been...
HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on May 23, 2024, at 4:15 p.m. ET...
HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock...
The new Gen-3 HALOโข Clarity 15 milliamp (mA) HOUSTON, TX, April 09, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) today announced it has...
HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the โCompanyโ or โNexalinโ) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions